Artesunate/Chlorproguanil/Dapsone

青蒿琥酯/氯丙胍/氨苯砜

Report date: 2022/07/19 20:00:45

Base Information

Drug NameArtesunate/Chlorproguanil/Dapsone
Drug Alias NameChlorproguanil/Dapsone/Artesunate青蒿琥酯/氨苯砜/氯丙胍Artesunate/Dapsone/Chlorproguanil氯丙胍/氨苯砜/青蒿琥酯Dapsone/Artesunate/Chlorproguanil +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDihydropteroate synthase inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors
TargetsDihydropteroate synthaseSarcoplasmic/endoplasmic reticulum calcium ATPase 2Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTanzaniaNigeriaBurkina Faso +[6] 
CombinationsYes Chlorproguanil HydrochlorideDapsoneArtesunate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWorld Health OrganizationGlaxosmithkline PlcUniversity Of Liverpool +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A